The Quantellect read.As of Nov 19, 2026, 13 active firms cover Xylem Inc: 9 rate it Buy or better, 4 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets span $110.00 to $165.00, a moderate spread. The average target of $142.18 sits 49% above the current $95.17. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.15 next quarter toward $5.85 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS13 active firms
Buy
Strong Buy00%
Buy969%
Neutral431%
Sell00%
Strong Sell00%
Based on 13 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$142.18
+49.4% upside
Average target across 11 active firms as of Nov 19, 2026 vs $95.17 current
Highest Target$165.00
Average Target$142.18
Lowest Target$110.00
Detailed analyst forecasts for XYL
Showing 1–14 of 14 named analysts shown · 13 active firms in the rating projection
As of Nov 19, 2026, 9 of 13 active firms rate XYL a Buy (4 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
XYL EPS & revenue forecast
EPS · NEXT QUARTER
$1.15
Range $1.05 – $1.22 · 14 analysts · +3% YoY
Next period, 14 analysts expect Xylem Inc to earn $1.15 a share (range $1.05 – $1.22), versus $1.12 a year earlier. Full-year consensus is $5.43, growing to $5.85 the year after.
REVENUE · NEXT QUARTER
$2.1B
Range $2.1B – $2.2B · 14 analysts · +0% YoY
Revenue is expected to reach $2.1B (range $2.1B – $2.2B), +0.3% year-over-year. Full-year consensus is $9.0B, rising to $9.3B next year.
Top analysts covering Xylem Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on XYL.
#1
Joshua Spector
UBS · Rank #56
Neutral
$112.00+17.7% to target
Overall win rate
50%
+ Follow
#2
Nathan Jones
Stifel · Rank #161
Buy
$114.00+19.8% to target
Overall win rate
47%
+ Follow
#3
Deane Dray
RBC Capital · Rank #329
Buy
$164.00+72.3% to target
Overall win rate
43%
+ Follow
#4
Bryan Blair
Oppenheimer · Rank #341
Buy
$135.00+41.9% to target
Overall win rate
38%
+ Follow
#5
Andrew Kaplowitz
Citigroup · Rank #351
Buy
$148.00+55.5% to target
Overall win rate
38%
+ Follow
XYL stock forecast FAQ
What is XYL's average 12-month price target?+
The 11 active firms with a live target average $142.18 for Xylem Inc over the next 12 months, ranging from a $165.00 high to a $110.00 low, as of Nov 19, 2026.
Is XYL stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 13 active firms as of Nov 19, 2026, 9 rate it Buy or Strong Buy, 4 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for XYL?+
The Street-high target is $165.00 (Baird), and the Street-low is $110.00 (Mizuho). The average of all 11 active-firm targets is $142.18.
How many active Wall Street firms cover XYL?+
13 active firms have a recognized rating on Xylem Inc as of Nov 19, 2026, and 11 active firms carry a live 12-month price target.
Who is the most accurate analyst covering XYL?+
Among analysts who currently cover XYL, Joshua Spector of UBS has the strongest overall Quantellect track record (Rank #56). Their current call is Neutral with a $112.00 target.
What is Xylem Inc's projected EPS for next quarter?+
The consensus estimate is $1.15 per share (range $1.05 – $1.22) across 14 analysts. Full-year EPS is projected at $5.43, rising to $5.85 the following year.
How much revenue is Xylem Inc expected to report next quarter?+
Consensus revenue is $2.1B (range $2.1B – $2.2B). Full-year revenue is projected at $9.0B, growing to $9.3B next year.
Have analysts been upgrading or downgrading XYL lately?+
As of Nov 19, 2026, 9 of 13 active firms rate XYL a Buy (4 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their XYL calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.